NDC 21695-723

AMRIX

Cyclobenzaprine Hydrochloride

AMRIX is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Rebel Distributors Corp.. The primary component is Cyclobenzaprine Hydrochloride.

Product ID21695-723_555ff988-280c-4272-bf1f-a911fe2e584d
NDC21695-723
Product TypeHuman Prescription Drug
Proprietary NameAMRIX
Generic NameCyclobenzaprine Hydrochloride
Dosage FormCapsule, Extended Release
Route of AdministrationORAL
Marketing Start Date2007-10-01
Marketing CategoryNDA / NDA
Application NumberNDA021777
Labeler NameRebel Distributors Corp.
Substance NameCYCLOBENZAPRINE HYDROCHLORIDE
Active Ingredient Strength15 mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 21695-723-14

14 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (21695-723-14)
Marketing Start Date2007-10-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 21695-723-28 [21695072328]

AMRIX CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021777
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-10-01
Inactivation Date2019-09-24

NDC 21695-723-14 [21695072314]

AMRIX CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021777
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-10-01
Inactivation Date2019-09-24

NDC 21695-723-60 [21695072360]

AMRIX CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021777
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-10-01
Inactivation Date2019-09-24

Drug Details

Active Ingredients

IngredientStrength
CYCLOBENZAPRINE HYDROCHLORIDE15 mg/1

OpenFDA Data

SPL SET ID:555ff988-280c-4272-bf1f-a911fe2e584d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 828358
  • 828359

    • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]

    NDC Crossover Matching brand name "AMRIX" or generic name "Cyclobenzaprine Hydrochloride"

    NDCBrand NameGeneric Name
    21695-723AMRIXAMRIX
    21695-953AMRIXAMRIX
    35356-262AmrixAmrix
    50090-1101AMRIXAMRIX
    63459-700AMRIXAMRIX
    63459-701AMRIXAMRIX
    0093-1920Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0093-1921Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0093-3420Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0093-3421Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0093-3422Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0115-1436Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0115-1437Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0179-0057cyclobenzaprine hydrochloridecyclobenzaprine hydrochloride
    0179-0189cyclobenzaprine hydrochloridecyclobenzaprine hydrochloride
    0378-0751Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
    0378-0761Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
    0378-0771Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
    0440-1350Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0440-7350Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0591-3256Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0591-3330Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0591-5658Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0615-3520Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
    0615-7528Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
    0615-8182Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
    0904-7809Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride

    Trademark Results [AMRIX]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    AMRIX
    AMRIX
    78261264 3353178 Live/Registered
    TEVA PHARMACEUTICALS INTERNATIONAL GMBH
    2003-06-11
    AMRIX
    AMRIX
    77307173 3684884 Live/Registered
    TEVA PHARMACEUTICALS INTERNATIONAL GMBH
    2007-10-18
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.